MCRT Webcast: High-Risk Disease Essentials
MC ROUND TABLES - January 16, 2021
High-risk disease poses the most difficult questions in myeloma treatment. Increasing knowledge about genetics provides information about which targets to... Read More
Change is Possible: Achieve your Myeloma Goals in 2021 with the Help of a Myeloma Coach
Change is Possible: Achieve your Myeloma Goals in 2021 with the Help of a Myeloma Coach
MYELOMA COACH - January 15, 2021
The start of a brand new year feels fresh and inspiring. It's a clean slate, a new start. It’s no wonder that this is the time many commit to new... Read More
American Society of Hematology Meeting Review: Register Now for the Myeloma Crowd Round Table Interactive Webcast on January 30
UPCOMING MC ROUND TABLES - January 15, 2021
Six Myeloma Experts Discuss ASH Studies Register Now The American Society of Hematology (ASH) meeting is the most important scientific... Read More
HealthTree University: Know Your Therapy (BETA) (Part 2 of 3)
HEALTHTREE - January 14, 2021
Editor’s note: These videos are still in the editing stages, but they have important information about your disease and the myeloma therapies pat... Read More
Our Next Show: Multiple Myeloma Care in 2021 with Robert Z. Orlowski, MD Anderson Cancer Center on Friday, January 22 at 3 pm Central
UPCOMING MC RADIO SHOWS - January 14, 2021
Friday, January 22, 2021 @ 1 pm Pacific, 2 pm Mountain, 3 pm Central, 4 pm Eastern Call In by Phone to Listen Live: (347) 637-2631 or Lis... Read More
Blood Type and Multiple Myeloma Outcomes
LIFE WITH MYELOMA - January 13, 2021
Does blood type matter when it comes to multiple myeloma? Turkish researchers shared new data in the Magazine of European Medical Oncology showing tha... Read More
Pesticide Use Linked to Myeloma Precursor Conditions
LIFE WITH MYELOMA - January 12, 2021
A recent study of male farmers shows that the use of certain types of pesticides are associated with the precursor condition of multiple myeloma called&nbs... Read More
Treating High Risk Multiple Myeloma Patients With or Without Elotuzumab: Is There Benefit for Everyone with Quad Therapies?
MYELOMA NEWS - January 11, 2021
Quad therapies are getting more attention as they may help extend or deepen responses for myeloma patients. Does the strategy work for high-risk patients as wel... Read More
Full Show: The IMPACT of COVID-19 on MGUS, Smoldering Myeloma, African Americans and Myeloma Patient Family Members
MC RADIO - January 11, 2021
Irene Ghobrial, MD Dana Farber Cancer Institute Interview Date: December 16, 2020 Thanks to our episode sponsor Summary How will COVID-19 affect ... Read More
S.M.A.R.T. Fitness Goals for 2021
MUSCLES FOR MYELOMA - January 09, 2021
This week was the start of our Fitness for Myeloma Chapter Event. It will be a continuing event each month, and we will be having a topic of focus each month. F... Read More
MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma
MC ROUND TABLES - January 08, 2021
Fear, uncertainty, and pessimism accompany virtually every cancer diagnosis, especially if most patients, like those with myeloma, have never even heard the wor... Read More
HealthTree University: Know Your Therapy (BETA) (Part 1 of 3)
HEALTHTREE - January 08, 2021
Editor’s note: These videos are still in the editing stages, but they they have important information about your disease and the myeloma therapie... Read More
An On/Off Switch for CAR T Therapy in Multiple Myeloma
MYELOMA NEWS - January 07, 2021
CAR T therapy is in development for multiple myeloma, but can come with toxic side effects called cytokine release syndrome, an overactive inflammatory res... Read More
